Pascal Deschatelets

Companies

• Apellis Pharmaceuticals, Inc.Chief Scientific Officer Feb 1, 2021 to now¹
• Apellis Pharmaceuticals, Inc.Chief operating officer Nov 8, 2017 to Mar 12, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• APApellis Pharmaceuticals, Inc.0 shares³May 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 14, 2026Returned to company 25,840 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Returned to company 11,284 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Returned to company 3,372 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Returned to company 4,909 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Returned to company 25,840 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Granted 25,840 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Returned to company 12,920 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Granted 12,920 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Returned to company 10,030 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Granted 10,030 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Returned to company 41,250 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Granted 41,250 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026U 1,177,222 shares of Apellis Pharmaceuticals, Inc.³
• Jan 28, 2026Granted 25,840 shares of Apellis Pharmaceuticals, Inc.⁴
• Jan 22, 2026Sold 5,928 shares at $21.77 of Apellis Pharmaceuticals, Inc.⁵
• Jan 20, 2026Sold 909 shares at $19.79 of Apellis Pharmaceuticals, Inc.⁶
• Jan 13, 2026Sold 2,277 shares at $22.19 of Apellis Pharmaceuticals, Inc.⁷
• May 21, 2025Exercised options 12,780 shares at $3.76 of Apellis Pharmaceuticals, Inc.⁸
• Jan 29, 2025Sold 826 shares at $29.52 of Apellis Pharmaceuticals, Inc.⁹
• Jan 22, 2025Sold 3,948 shares at $30.43 of Apellis Pharmaceuticals, Inc.¹⁰
• Jan 21, 2025Granted 15,045 shares of Apellis Pharmaceuticals, Inc.¹¹
• Jan 17, 2025Sold 750 shares at $29.96 of Apellis Pharmaceuticals, Inc.¹¹
• Jan 13, 2025Sold 2,288 shares at $28.70 of Apellis Pharmaceuticals, Inc.¹²
• May 20, 2024Exercised options 24,500 shares at $3.76 of Apellis Pharmaceuticals, Inc.¹³
• May 8, 2024Sold 100 shares at $44.03 of Apellis Pharmaceuticals, Inc.¹⁴